POLYCYTHEMIA VERA

Clinical trials for POLYCYTHEMIA VERA explained in plain language.

Never miss a new study

Get alerted when new POLYCYTHEMIA VERA trials appear

Sign up with your email to follow new studies for POLYCYTHEMIA VERA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 14 Not yet recruiting 1 Not yet finished but already full! 9 Completed 4 Terminated 1

AI predicts when blood cancer drugs fail

Disease control Terminated

This study aimed to confirm if a computer model could accurately predict when a standard drug (hydroxyurea) would stop working for patients with polycythemia vera, a type of blood cancer. It observed 76 adult patients in Germany who were starting the drug for the first time. The …

Matched conditions: POLYCYTHEMIA VERA

Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

POLYCYTHEMIA VERA

Get alerted when new POLYCYTHEMIA VERA trials appear

AI predicts when blood cancer drugs fail